2025 International Congress Archives

Can Wearable Inertial Sensors Accurately Reflect Parkinson’s Disease Severity? A Systematic Review and Meta-Analysis

H. Youssef, M. Sabıroğlu, S. Abdelrahman, T. Hasanin, M. Manay, M. Gönül, S. Del Din, A. Vural (Istanbul, Turkey)
CAP-003, a CNS-targeted IV-delivered AAV Gene Therapy Developed for Patients with Parkinson’s Disease associated with GBA1 Mutations

K. Mcdowell, R. Ressler, M. Flynn, B. Wheeler, L. Grigoryeva, A. Armendariz, H. Acharya, P. Denis, J. Granados, P. Tchourilov, C. Pedeferri, M. Brandabur, S. Tole, N. Goeden, N. Flytzanis (Thousand Oaks, USA)
CAPOS Phenotypic Spectrum: CAPOS, CAPOS+ and CAPOS- within the p.Glu831Lys Variant of the ATP1A3 gene. Case Report and Literature Review.

E. Olivas-Domínguez, R. Romero-Armenta, M. Ramírez-García, H. Martínez-Hernández (Mexico City, Mexico)
Carbidopa/levodopa related hypotension in patients with alpha-synucleinopathies

D. Rebolledo, JA. Romero-Mera, JC. Lopez-Hernandez, M. Groccopatel-Marra, A. Gonzalez-Duarte, P. Millar Vernetti, H. Kaufmann (New York, USA)
Cardiac Autonomic Dysfunction in Patients with Multiple System Atrophy and Spinocerebellar Ataxia: A Comparative Study and Distinctive Machine Learning Model

P. Sathirapanya, N. Limotai, C. Limotai, N. Suanprasert, S. Rujirussawarawong, C. Kongkamol, N. Cheetanom (Bangkok, Thailand)
Caregiver and Patient perspectives on Parkinson’s Disease at tertiary, urban teaching hospital in Zambia, Africa: A Focus Group Study

J. Purks, G. Habanyama, L. Chishimba (Rochester, USA)
Caregiver Burden after DBS at GPI or STN for Parkinson’s Disease

A. Kamath, H. Branstetter, J. Summers, T. Hassell, S. Bick, N. Banerjee, K. Dhima (Nashville, USA)
Caregiver Contribution to self-care in people with Parkison’s Disease: a meta-synthesis

C. Tedesco, M. Petralito, R. Caruso, I. Milani, G. Pucciarelli (Rome, Italy)
Carvacrol modulates rotenone-induced Nigrostriatal Neuronal Death and Angiogenesis via targeting AMPK/FOXO3 transcription factor O3 Signaling cascade

D. Singh (Allahabad, India)
Case report and Literature Review on Atypical Parkinson’s Disease

MJ. Dashdorj (Ulaanbaatar, Mongolia)
Case Report of a Brazilian Family With New VUS for PLAN

M. Medeiros, M. Augustin (Porto Alegre, Brazil)
Case Report of an 82 Year Old Man with an 18 Year History of REM Sleep Behavior Disorder and Colonic Lewy Pathology

K. Minemura, A. Kawanami, A. Horita, M. Hara, Y. Saito, S. Murayama, K. Hasegawa (Kanagawa, Japan)
Case Report: An Atypical Presentation of Runner’s Dystonia

M. Soliman, A. Mushtaheed, A. Gravunder, J. Matsubara, C. Stanley, C. Zampieri-Gallagher, D. Ehrlich, K. Alter, A. Ly (Bethesda, USA)
Case Report: Atypical Parkinsonism Revealed as PLAG26-Associated Neurodegeneration (PLAN) on Genetic Testing

Z. Bonzell, M. Bruno (Honolulu, USA)
Case Report: Effect of DBS in a Patient with Cerebellar Atrophy

A. Salisbury, A. Brucker, A. Zakharova, A. Mousavi, J. Maclean, J. Olaya, M. Liker, T. Sanger (Vitacura, Región Metropolitana, Chile)
Case Report: Painful Limb and Moving Fingers Syndrome

M. Soliman, A. Mushtaheed, A. Ly, D. Ehrlich (Bethesda, USA)
Case Series of 13 Hereditary Ataxia Patients From The Chiloe Islands, Chile.

E. Fernandez-Toledo, HM. Chaparro-Solano, P. Saffie-Awad (Cleveland, USA)
Caution in the creation of Parkinson’s disease cognitive composites

D. Gonzalez, A. Karstens, J. Fleisher, S. Patel, C. Goetz (Chicago, USA)
Cell-type specific bidirectional modulation of STN neurons rescue Parkinsonian motor symptom.

JH. Shin, HK. Chung, JH. Kim, JS. Yook, J. Kim, B. Jeon (Seoul, Republic of Korea)
Center of Mass and Center of Pressure interactions during Gait in people with Parkinson’s Disease

D. Tosatto, D. Bonacina, F. D'Andrea, C. Perin, C. Alessandro, D. Piscitelli (Milano, Italy)
Central Neuromodulatory Effects of Sodium Oxybate in Laryngeal Dystonia: A Pharmacological fMRI Study

L. O'Flynn, A. Hamzehei Sichani, A. Worthley, N. Sharma, P. Song, K. Simonyan (Boston, USA)
Cerebellar connectivity predicts early response to GPi-DBS in dystonia.

A. Martinez Nunez, V. Chandra, C. Fleeting, A. Patel, A. Fusco, J. Wong (Gainesville, USA)
Cerebellar Syndrome and Parkinsonism Associated with Acquired Hepatocerebral Degeneration with Unusual Findings on Neuroimaging.

R. Sanjinez, J. Bestoso (Buenos Aires, Argentina)
Cerebello-Thalamo-Cortical Tract Microstructural Changes in Parkinson’s Disease Patients with Tremor

I. Cruz, M. Wilken, G. álvarez, M. Villarreal, M. Merello (Buenos Aires, Argentina)
Cerebral Glucose Metabolic Features of GBA-Parkinson’s Disease as a window into cognitive impairment

P. Mitrotti, R. Calabrese, M. Picascia, L. Gallo, R. Malito, A. Panzacchi, C. Galandra, M. Todisco, R. Zangaglia, D. Perani, A. Chiti, EM. Valente, C. Tassorelli, S. Camminiti, M. Avenali (Pavia, Italy)
Cerebral Vasoreactivity and Neuropsychiatric Features in Parkinson’s disease.

M. Cansino Torres, D. Ortiz Zacarias, S. Castillo Torres, R. Lopez Soto, J. Trejo Ayala, A. Infante Valenzuela, F. Gongora Rivera, B. Chavez Luevanos, I. Estrada Bellmann (Monterrey, Mexico)
Cerebrospinal fluid DOPA decarboxylase levels as a marker of disease severity in Parkinson’s Disease

K. Groenewald, L. van Hillegondsberg, T. Eisenstein, J. Klein, M. Hu (Oxford, United Kingdom)
Cerebrospinal fluid measured α-synuclein is related to metabolite profile in the serum and CSF

K. Paul, D. Jones, B. Ritz (Los Angeles, USA)
Cerebrotendinous Xanthomatosis successfully treated with Chenodeoxycholic Acid Supplementation

N. de Jong, J. Carr, D. Marais (Cape Town, South Africa)
Challenges in Airway Management after Deep Brain Stimulation in DYT1 Dystonia: a Case Report

CE. Wang, CF. Hu, YH. Chen, YF. Sung (Taipei City, Taiwan)
Challenges in Diagnosing and Managing Multiple System Atrophy in Low-Resource Settings: Insights from Nepal

A. Chandra, A. Chandra, S. Acharya (Kathmandu, Nepal)
Challenges in the Diagnosis and Management of Functional Movement Disorders in a Developing Nation: Insights from the Philippines

KA. Pañares, A. Lang, G. Saranza (Cebu, Philippines)
Changes in Cognitive Function with Deep Brain Stimulation in PD patients with and without Freezing of Gait

V. Basavatia, K. Kwei (New York, USA)
Changes in Functional Movement Disorders (FMD) Phenotype: A Retrospective Study

D. Marín-Medina, G. Lopez, M. Rossi, M. Merello (Buenos Aires, Argentina)
Changes in Inhibitory Control Differentiate Progressive Supranuclear Palsy from Early Parkinson’s Disease

B. Couto, F. Castano, J. Carrillo, M. Roca, A. Chade, O. Gershanik, G. Gomez-Arevalo (Buenos Aires, Argentina)
Changes in Motor States Throughout the Waking Day With Tavapadon in People With Parkinson’s Disease

R. Hauser, R. Pahwa, L. Harmer, A. Lind (Tampa, USA)
Characterising Peripheral Innate Immune Cell Infiltration into the Brain in Parkinson’s Disease

C. Tournerie, B. Patel, A. Quaegebeur, C. Williams-Gray (Cambridge, United Kingdom)
Characteristics and Trends of Parkinson’s Disease Patients Receiving Deep Brain Stimulation: Insights From a US All-Payer Health Administrative Claims Database

W. Zhang, M. Bharadwaz, A. Gabriel, J. Weber, M. Frick, A. Yaldo, C. Gøtzsche, T. Machewitz, J. Lott (Whippany, USA)
Characteristics of apathy in clinical forms of Parkinson’s disease

O. Naimov, R. Matmurodov, S. Jumanazarova, B. Muminov (Tashkent, Uzbekistan)
Characteristics of IncobotulinumtoxinA Treatment for Cervical Dystonia in a Real-World Setting: Dosing and Muscles Injected

J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)
Characteristics of IncobotulinumtoxinA Treatment for Limb Spasticity in a Real-World Setting: Dosing and Muscles Injected

J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)
Characteristics of Visual Hallucinations in Lewy Body Dementia

Y. Luo, RY. Lo, J. Wang (Hsinchu, Taiwan)
Characterization of autonomic dysfunction in prodromal and early stages of Parkinson’s Disease

I. Cani, L. Baldelli, P. Guaraldi, B. Calò, G. Carrozzo, F. Di Laudo, G. Giannini, L. Sambati, P. Cortelli, F. Provini, G. Calandra-Buonaura (Bologna, Italy)
Characterization of Autonomic Dysfunction Profiles in Early Parkinson’s disease

Q. Yuan, F. Sarmento, V. Lavu, A. Madamangalam, J. Wong (Gainesville, USA)
Characterization of DBS-induced Speech Improvements in a German PD Cohort

G. Brandt, K. Simon, T. Dembek, M. Barbe, T. Thies (Cologne, Germany)
Characterization of neuronal exosomes purified from plasma of Parkinson’s Disease Chilean patients

V. Urbina, C. Aguilera, E. Larraechea, D. Sepulveda, R. Vidal (Santiago, Chile)
Characterization of the Dnajc13 p.N860S mouse model, a physiological model of alpha-Synuclein overexpression

J. Follett, J. Fox, I. Deng, S. Wall, A. Rajput, A. Rajput, M. Farrer (Gainesville, USA)
Characterizing the Neural Signature of Parkinsonian Freezing of Gait During an Immersive Virtual Reality Paradigm

M. Miller Koop, A. Rosenfeldt, K. Scelina, L. Scelina, C. Waltz, A. Bazyk, V. Berki, K. Baker, N. Malan, S. Nagel, B. Walter, J. Liao, K. Baker, J. Alberts (Cleveland, USA)
Characterizing the Patient Clinical Journey Before and After Diagnosis of Friedreich Ataxia and Differences by Age at Diagnosis

A. Henriquez, M. Hatcher, B. Bian, A. Didonato, S. England, Q. Ip, X. Ma, J. Mckay, R. Avila (Seattle, USA)
Cholinergic activity associates with cognitive function in PD using [18F]VAT

J. O'Donnell, A. Eid, H. Hwang, S. Grossen, J. Hood, E. Foster, Z. Tu, J. Perlmutter, M. Campbell (St. Louis, USA)
Chorea as the initial presentation of Erdheim-Chester disease

I. Sarac, H. Sarac, S. Basic Kinda, F. Borovecki, N. Henigsberg, L. Lugovi Mihic (Zagreb, Croatia)
Chorea-acanthocytosis in Puerto Rico: A Case Series

E. Pérez-Luciano, C. Chapel-Crespo, D. Lozada-Figueroa, I. Pita-García, L. Surillo-Dahdah (Ponce, Puerto Rico)
Chorea,dystonia, and tics:lessons learned from the clinical pattern associated with VPS13A disease

H. Saglam, J. Frey (Morgantown, USA)
Chronic DBS Stimulation’s effects after 1-hour off stimulation

M. Varga, Y. Zhao, S. Santacruz (Austin, USA)
Chronic Exercise and Systemic Inflammation in Parkinson’s Disease: Exploring the Role of Exercise Modality

J. Cristini, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)
Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: A longitudinal study

K. Baik, M. Park, M. Kang, YJ. Park, SJ. Chung, K. Oh, SH. Kang, S. Koh (Seoul, Republic of Korea)
Circadian Rhythms: Role in Movement Disorders and associated Sleep Disturbances.

S. Yadav, S. Buggana (Tirupati, India)
CJD presenting as unilateral upper limb dystonia- rare presentation of an uncommon disease.

N. Sawal, M. Matta, A. Kaur, S. Anand (Chandigarh, India)
Classification of Medication State in Parkinson’s Disease Patients with and without Fluctuations using Facial Videos

I. Boura, V. Skaramagkas, G. Karamanis, I. Kyprakis, D. Fotiadis, Z. Kefalopoulou, M. Tsiknakis, C. Spanaki (Heraklion, Crete, Greece)
Clinical analysis of sarcopenia prevalence and its influencing factors in patients with Parkinson’s disease

R. Morimoto, K. Kitagawa, K. Todo, M. Iijima (Tokyo, Japan)
Clinical And Cerebellar Structural Alterations In Parkinson’s Disease Patients With Freezing Of Gait

E. Sarasso, A. Gardoni, A. Grassi, L. Zenere, S. Basaia, G. Bonardi, S. Carta, I. Di Vico, E. Mantovani, E. Canu, M. Bressan, V. Castelnovo, E. Sibilla, C. Tripodi, F. Freri, R. Balestrino, M. Trentinaglia, F. Maffei, V. Chiodega, S. Tamburin, MA. Volontè, S. Mariotto, M. Tinazzi, M. Filippi, F. Agosta (Milan, Italy)
Clinical and Dopaminergic Characteristics of MSA-C Patients with Predominant Cerebellar Asymmetry

DG. Park, YS. Kim, YS. An, JH. Yoon (Suwon, Republic of Korea)
Clinical and Electrophysiological Features of Hypertrophic Olivary Degeneration

YCT. Tai, TKL. Lin (Kaohsiung, Taiwan)
Clinical and epidemiological characterization of patients with cerebellar ataxia in a reference center in Northeastern Brazil

V. Chagas, M. Soares, M. Bezerra (Recife, Brazil)
Clinical and Genetic Characteristics of PLA2G6-parkinsonism in Southwest China and a Comprehensive Literature Review

YF. Cheng, HF. Shang (Chengdu, China)
Clinical and Genetic Profile of DYT-THAP1 in Asian Indian Patients

D. Radhakrishnan, A. Saini, K. Tayade, V. Holla, N. Kamble, P. Kukkle, A. Agarwal, D. Garg, L. Patil, M. Chandarana, N. Barad, N. Kumar, E. Arunmozhimaran, A. Srivastava, M. Bhatt, P. Pal, R. Rajan (Indore, India)
Clinical and Genetic profile of patients presenting with Adult-onset cerebellar ataxia of probable genetic aetiology

H. R S, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Clinical and Genetic spectrum of Developmental dyskinetic encephalopathy – Experience from a Tertiary care centre

A. Vijayaraghavan, S. Nair, S. Sundaram (Thiruvananthapuram, India)
Clinical and Genetic Spectrum of Early-Onset Cerebellar Ataxia in India: A Tertiary Care Center Experience

M. Raval, V. Holla, G. Arunachal, R. Raghavendra, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Clinical and neuro-imaging predictors of falls in PLA2G6-related Parkinsonism: a retrospective study

C. Chen, Y. Sun, H. Dai, F. Liu, . Jun, X. Liu, J. Wang (Shanghai, China)
Clinical and Neuroimaging Findings in ANO10-Related Cerebellar Ataxia: Evidence of Widespread Brain Atrophy

A. Milovanović, O. Tamaš, N. Mazalica, S. Pisano, S. Basaia, F. Agosta, M. Filippi, V. Kostić, N. Dragašević-Mišković (Milan, Italy)
Clinical and paraclinical aspects of extrapyramidal disorders in patients with cerebrovascular pathology

S. Jumanazarova, R. Matmurodov, E. Abduqodirov, A. Kalanov, S. Mamatova (Tashkent, Uzbekistan)
Clinical and Pathological Features of CSF1R-Related Disorder Associated with the c.2330G>A, p.R777Q Pathogenic Variant

T. Chmiela, A. Strongosky, D. Dickson, Z. Wszolek (Katowice, Poland)
Clinical case of cerebellar ataxia associated with temporal bone tumor

B. Mukhammedaminov, N. Aripova, L. Kenjaeva, Y. Nishonova (Tashkent, Uzbekistan)
Clinical case of Sporadic adult-onset ataxia

N. Aripova, L. Kenjaeva, B. Bakhtiyor, Y. Nishonova (Tashkent, Uzbekistan)
Clinical Characteristics and Antipsychotic Medication Use in Pediatric Population Diagnosed With Tourette Syndrome

K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Boston, USA)
Clinical Characteristics and Biomarkers in Parkinson’s Disease Patients with Body-first versus Brain-first Subtypes in Parkinson’s Disease

S. Li, Y. Tang, J. Wang (Shanghai, China)
Clinical characteristics and motor dysfunction in probable REM sleep behavior disorder(pRBD): Insights from CHECK-PD community-based screening project

PL. Lean, J. Sringean, T. Saengmanee, P. Rattanajun, A. Chaisongkram, R. Bhidayasiri (Bangkok, Thailand)
Clinical Characteristics of Parkinsons Disease and their Role in Differential Diagnosis

M. Ganieva, L. Tolibova (Dushanbe, Tajikistan)
Clinical Characteristics of Sporadic Parkinson’s Disease with Negative CSF Alpha-synuclein Seed Amplification Assay

S. Brooker, J. Pasquini, S. Choi, D. Lafontant, K. Marek, T. Simuni, P. Gonzalez-Latapi, N. Pavese, K. Poston (Chicago, USA)
Clinical Deficits, Quality of Life and Caregiver Burden across PSP Phenotypes

A. Cámara, I. Zaro, C. Painous, Y. Compta (Barcelona, Spain)
Clinical Differences Among Parkinson’s Disease Patients Carrying GBA1 Variants in Colombia: Insights From LARGE-PD Consortium

T. Lopez Gonzalez, S. Poveda, HM. Chaparro Solano, J. Ramchandra, E. Waldo, L. Santiago, T. Leal, M. Inca, O. Bernal-Pacheco, G. Arboleda Bustos, H. Arboleda, C. Cerquera, L. Quintero-Giraldo, C. Moreno-Gonzalez, B. Muñoz-Ospina, JL. Orozco, DA. Pineda, O. Buritica, D. Aguillon, M. Jimenez-Del Rio, C. Velez-Pardo, IF. Mata (Cleveland, USA)
Clinical Diversity Of Patients Attending To The Istanbul Medipol University Parkinson’s Disease And Movement Disorders Center (Parmer) Who Did Not Undergo Dbs Surgery

OZG. Koksal, GLN. Ibrahimova, SED. Bostan, BSK. Bolluk Kılıc, NES. Helvaci Yılmaz, YAK. özsezer, BUS. Ari, ALI. Zirh, GUL. Kenangil (istanbul, Turkey)
Clinical Efficacy of a Novel Deep Brain Stimulation System with 16-contact Directional Leads for the Treatment of Parkinson’s Disease

F. Morgante, J. Fitzgerald, S. Vinke, R. Schuurman, C. Matthies, A. Andrea Kühn, V. Visser-Vandewalle, A. Gharabaghi, D. Pedrosa, V. Coenen, R. Shivacharan, E. Goldberg (London, United Kingdom)
Clinical Efficacy, Cost Effectiveness, and Caregiver Satisfaction of the Application of Parkinson’s KinetiGraph (PKG) in Clinical Practice versus Standard Care – a 12-month Longitudinal Analysis Part of the EmPARK-PKG Project

V. Metta, M. Qamar, H. Benamer, T. Loney, G. Goyal, R. Dhamija, P. Kukle, R. Borgohain, R. Mridula, H. Hussain, A. Nalarakettil, R. Chaudhuri (London, United Kingdom)
Clinical Experience with Mixed System Deep Brain Stimulation (DBS): Retrospective Analysis

Y. Pathak, P. Waguespack, P. Silburn (Plano, USA)
Clinical Features of Essential Tremor and Its Impact on Quality of Life in Japan.

S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)
Clinical Features of Juvenile Parkinson Disease: a Comparative Study with Early-Onset Parkinson Disease

L. Malfer, C. Piat, A. Mullan, K. Coffman, R. Savica (Rochester, USA)
Clinical Features of Patients with Functional Movement Disorders: Experience of a Movement Disorders Center in Kazakhstan

G. Saidakhmetova, ZH. Myrzayev (Almaty, Kazakhstan)
Clinical Features Suggestive of Alpha-Synucleinopathy in Progressive Supranuclear Palsy

C. Painous, A. Martínez-Reyes, J. Santamaria, M. Fernández, A. Cámara, Y. Compta (Barcelona, Spain)
Clinical Improvement after Deep Brain Stimulation is associated with the Suppression of Pallidal low-frequency Oscillations in Patients with Dystonia

C. Palmisano, J. Del Vecchio, I. Hanafi, A. Al Habbal, C. Matthies, G. Pezzoli, J. Volkmann, P. Capetian, N. Pozzi, S. Haufe, I. Isaias (Wuerzburg, Germany)
Clinical Manifestations and Rate of Progression of Parkinsons Disease in Different Regions

M. Qurbonova, M. Isrofilov (Dushanbe, Tajikistan)
Clinical Picture of Acute Akinetic Collapse Leading to Multi-Day Immobility in Parkinson’s Disease

S. Kobayashi, Y. Hagihara, M. Inoue, J. Nakamura, T. Chiba, K. Hokkoku (Tokyo, Japan)
Clinical predictors of home-based motor learning of touchscreen skills in Parkinson’s disease

J. de Vleeschhauwer, E. Nackaerts, N. D'Cruz, M. Gilat, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)
Clinical Profile and 18F -Fluorodopa Positron Emission Tomography (18F -DOPA PET) Findings in a Movement Disorder Clinic Patient Cohort

S. Yellaturi, M. Prabhu, A. Behera, S. Pandey (Faridabad, India)
Clinical Progression and Biomarkers in Spinocerebellar Ataxia Type 31, A Form Unique to and Common in Japanese.

H. Aoki, K. Ishikawa (Tokyo, Japan)
Clinical Progression and Genetic Pathways in Body-First and Brain-First Par-kinson’s Disease

M. Passaretti, D. Veréb, M. Mijalkov, Y. Chang, H. Zhao, J. Sun, B. Zufiria Gerbolés, G. Volpe, N. Rivera, M. Bologna, J B. Pereira (Stockholm, Sweden)
Clinical subtypes and Radiological patterns in Progressive supranuclear palsy: A Prospective study

K. Gulati, S. Pandey (Faridabad, India)
Clinical validity of a digital toolkit combining active and passive assessments in early Parkinson’s Disease

J. Lavine, J. Bakker, G. Stephenson, A. Scotina, A. Amara, M. Dockendorf, R. Ellis, S. Frank, O. Harari, S. Isaacson, O. Levy, P. Lewitt, J. Liebenthal, E. Mangin, Z. Mari, J. Morgan, O. Patil, B. Rankin, J. Ren, R. Rodriguez, S. Stoch, D. Tu, S. Upadhyay, J. Urbanek, M. Wipperman, L. Omberg, J. Wagner (New York, USA)
Clinician Advisory Community: Guiding The Michael J. Fox Foundation’s Mission Through Front-Line Intelligence

R. Dolhun, D. Kumbroch, K. Klapper, K. Wu, L. Holding, K. Callahan (New York, USA)
Clinicians’ Views on the Use of a Patient Decision Aid for DBS in Parkinson’s Disease

H. King, J. Blumenthal-Barby, B. Levi, S. de Jesus, L. Cabrera (University Park, USA)
Closed-Loop Electrical Stimulation Reduces Tremor and Decreases Tremorogenic Neural Drives in Essential Tremor: A Case Report

X. Yu, N. Kurukuti, H. Hassanlouei, G. Hoo, E. Roth, J. Pons (Chicago, USA)
Clustering and Identification of Parkinson’s Disease Severity Subtypes Using Multimodal Data and Machine Learning Approaches

H. Park, C. Youm, H. Choi, J. Hwang, M. Kim (Busan, Republic of Korea)
Co-existence of Myasthenia Gravis and Parkinson’s disease, plus essential tremor in a veteran at Camp Lejeune

Y. Kim, K. Colletta (Maywood, USA)
Co-Occurrence of DAT Scan, Amyloid PET Scan, and Alzheimer’s Genetic Screening Abnormalities in Patient with Early-Onset Neurocognitive Decline: A Case Report

A. Mason, R. Payne, N. Shneyder, E. Baldinger (Tampa, USA)
Co-occurrence of Parkinson Disease and Myasthenia Gravis in Hospitalized Patients: A Nationwide Analysis

S. Abdul-Ghani, J. Miles (Honolulu, USA)
Co-occurrence of Spinal Muscular Atrophy Type 2 and Huntington’s Disease

U. Agarwal, S. Fu, Y. Wang, B. Bulica (Detroit, USA)
Cognitive and Motor Wobbling in Isolated RBD: A Multicentric Study by the International RBD Study Group (IRBDSG)

A. Stefani, S. Joza, D. Arnaldi, L. Baldelli, G. Benbir, B. Boeve, V. de Cock, L. Churchill, B. Högl, M. Hu, B. Huang, R. Kim, K. Kufer, J-Y. Lee, C. Liguori, B. Mollenhauer, L. Muntean, N. Li, B. Orso, M. Patyjewicz, R. Postuma, F. Provini, S. Lewis, C. Simonet, M. Sommerauer, A. Videnovic, Y. Wing, C. Trenkwalder (Innsbruck, Austria)
Cognitive and Neuropsychiatric Dysfunction is Associated with Corticostriatal Synucleinopathy in the Alpha-Synuclein Preformed Fibril Rat Model of Parkinson’s Disease

J. Bechtold, J. Patterson, C. Kemp, A. Stoll, S. Arrington, M. Venard, L. Mayle, V. Field, J. Holden, C. Sortwell, S. Fleming (Rootstown, USA)
Cognitive Assessment in Parkinson’s Disease: A Mixed Methods Study of Current Neuropsychology Practices in Australia

J. King, D. Pourzinal, J. Yang, D. Brooks, D. Sriram, K. Sivakumaran, L. Mitchell, N. Dissanayaka (HERSTON, Australia)
Cognitive Biases in Movement Disorders: Implications for Clinical Decision-Making and Patient Perception of Symptoms

N. Choudhury, D. Buonadonna, B. Carr (Gainesvile, USA)
Cognitive Changes after bilateral Thalamic VIM DBS: A Single Center Experience

A. Boddu, L. Isaac, J. Newsom, A. Franklin, H. Schweitzer, T. Virmani, E. Petersen, J. Gess (Little Rock, USA)
Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors

L. Ge, K. Asai, K. Ogawa, K. Ikenaka, Y. Kimura, H. Mochizuki (Suita, Japan)
Cognitive Effects of Istradefylline in Parkinson’s Disease: A 26-Week Open-Label Pilot Study

M. Barrett, R. Heo, N. Mukhopadhyay (Richmond, USA)
Cognitive Improvement in Parkinson’s Disease Patients After Intravenous Mesenchymal Stem Cell Infusion: Results from a Phase 2 Randomized Trial

T. Thomas, J. Martinez-Lemus, E. Tharp, C. Green, C. Onuigbo, J. Suescun, T. Le, E. Rodarte Rascon, R. Ritter Iii, T. Ellmore, M. Schiess (Houston, USA)
Cognitive Load Modulates Excitability of Subthalamic Motor Circuitry in Parkinson’s Disease

V. Zapata, G. Marin, D. Parra, J. Ailsworth, J. Cordoba, E. Chen, M. Lowe, S. Jones, B. Walter, R. Rammo, S. Nagel, A. Machado, K. Baker, D. Escobar (Cleveland, USA)
Cognitive outcomes in thalamic deep brain stimulation for essential tremor: evaluating effect of anesthetic exposure and surgical approach

S. Iwamoto, C. Block, T. Parks, J. Saurman, D. Loring, E. Staikova, S. Miocinovic, R. Tripathi (Atlanta, USA)
Color Vision In Patients With Clinical Manifestations Of Rem Sleep Behavior Disorder

F. Tressino, G. Pereira, N. Bruscato, C. Rieder, A. Schuh (Porto Alegre, Brazil)
Combined Neuromodulative Treatment of Generalized Dystonia.

V. Mandat, H. Koziara, K. Szalecki, E. Soltan, P. Zdunek, B. Krolicki, T. Mandat (Toronto, Canada)
Combining Machine Learning and Linear Mixed Models to Estimate Medication Effect in People with Parkinson’s Disease

A. Castro Mejia, S. Sapienza, L. Pavelka, R. Kruger, J. Klucken (Belvaux, Luxembourg)
Combining Pharmaceutical and Digital Treatment Approaches in Parkinson’s Disease Modulates of the Limbic System, Supporting Emotional Regulation and Motivated Behaviors

N. Saporta, M. Catalogna, T. Tamir, R. Sivan Hoffmann, A. Amedi (Ramat Gan, Israel)
Community Awareness of Parkinson’s Disease as a Driver of Stigma in Kilifi, Kenya

N. Fothergill-Misbah, S. Unda, V. Nyadimo, M. Bitta (Newcastle upon Tyne, United Kingdom)
Comparative Analysis of miR-29a Expression in Optimized Medical Therapy and Intestinal Infusion Therapies in Advanced Parkinson’s Disease

I. Straka, S. Valaskova, Z. Andre, M. Minar, J. Kyselovic, A. Gazova (Bratislava, Slovakia)
Comparative Analysis of MoCA Scores Between Latin American Latinos and White Patients with Parkinson’s Disease

S. Sperling, S. Anis, H. Mauricio Chaparro-Solano, T. Peixoto Leal, C. Sonneborn, C. Callegari Piccini, M. Inca-Martinez, M. Cornejo-Olivas, M. Illanes-Manrique, P. Chana-Cuevas, P. Safie Awad, A. Jimena Hernández-Medrano, A. Cervantes-Arriaga, A. Schuh, C. Rieder, P. Braga-Neto, A. Silva Sena, B. Lopes Santos-Lobato, E. Gatto, G. Alvarado, C. Avila, V. Tumas, M. Paula Foss, V. Borges, H. Ballalai Ferraz, J. Orozco Vélez, B. Muñoz Ospina, S. Moreno, D. Pineda, J. Rios Pinto, P. Olguín, J. Cristobal Nuñez, A. Viñuela, A. Espinal-Martinez, N. Mori, K. Mejía-Rojas, A. Medina-Colque, A. Zuma Rosso, C. Vilaça, E. Ochoa-Valle, I. Cornejo-Herrera, P. Reyes-Perez, A. Lázaro-Figueroa, A. Moraes Alves, R. Gisbert Cury, H. Fernandez, I. Mata (Cleveland, USA)
Comparative Analysis of Trunk Sensor Placement for Movement Data Collection in the OxQUIP Study

C. Sotirakis, A. Pelliet, N. Conway, S. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)
Comparative Effectiveness of Botulinum Toxin vs. Oral Medications in the Management of Cervical Dystonia: A Multi-Center Study

A. Chandra, A. Chandra, S. Acharya (Tianjin, China)
Comparative Efficacy and Safety of Opicapone in Parkinson’s Disease: An Updated Systematic Review and Meta-Analysis

A. Abunamoos, Y. Aljazi, F. Qtaishat, A. Rababah, M. Mustafa, F. Alnajjar, M. Alghaniem (Amman, Jordan)
Comparative Efficacy and Safety of VMAT2 Inhibitors for Chorea in Huntington’s Disease: A Systematic Review and Meta-Analysis

A. Abunamoos, M. Mustafa, F. Alnajjar, Y. Aljazi, K. Moghib, N. Hamam, M. Alghaniem (Amman, Jordan)
Comparative efficacy of opicapone and entacapone in the management of motor fluctuations in Parkinson’s disease

S. Isaacson, F. Amjad, S. Thakkar, D. Martins, H. Brigas, G. Banisadr, S. Fisher (Boca Raton, USA)
Comparative Safety of Different Routes of Apomorphine Administration in Parkinson’s Disease: A Systematic Review and Meta-Analysis

A. Al Midani, A. Ahmad, O. Razouk, L. Mohamedali, M. Al Khalidi, B. Al Karam, A. Khater (Sharjah, United Arab Emirates)
Comparative Study of limits of stability Improvements in Young-Onset vs. Late-Onset Parkinson’s Disease Following One-Year Biofeedback Balance Training

MYA. Amine, YM. Mahmoud, FAR. Mehana, MAY. Hosny (Cairo, Egypt)
Comparing the Impact of Levodopa versus Pramipexole on Eye-Tracking Parameters in Treatment-Naïve Parkinson’s Disease: A Longitudinal Study

Z. Kosutzka, L. Hapakova, I. Straka, A. Kusnirova, M. Minar (Bratislava, Slovakia)
Comparison of 3 Tests for Subjective Cognitive Complaints in Early Parkinson’s Disease

R. Hoe, S. Ng, R. Chen, X. Choi, D. Heng, S. Neo, K. Tay, W. Au, E. Tan, L. Tan, Z. Xu (Singapore, Singapore)
Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)
Comparison of MIBG Uptake in the Major Salivary Glands Between Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease

J. Ebina, S. Mizumura, M. Shibukawa, J. Nagasawa, T. Hirayama, N. Ishii, Y. Kobayashi, A. Inaba, S. Orimo, O. Kano (Tokyo, Japan)
Comparison of Microglial PET Imaging in Parkinson’s Disease, RBD, and Controls with a CSF1R and TSPO Ligand.

K. Mills, I. Cheong, Y. Du, J. Coughlin, A. Horti, C. Motley, R. Dannals, W. Lesniak, T. Dawson, M. Pomper (Baltimore, USA)
Comparison of Prodromal Features between Parkinson’s Disease and Dementia with Lewy Bodies over 15 Years

G. Scott, S. Karki, J. Quinn, L. Neilson (Portland, USA)
Comparison of subthalamic nucleus and globus pallidus internus as deep brain stimulation targets for freezing of gait in Parkinson’s disease

M. Girija, C. Reddy, H. Chovatiya, S. Joshua, A. Nair, M. Chacko, A. Kishore (Kochi, India)
Compensatory Dynamic Brain Network Mechanisms in Early Lewy Body Dementia: An rs-fMRI Study

N. Němcová Elfmarková, ľ. Nováková, M. Gajdoš, I. Rektorová (Brno, Czech Republic)
Complement C4 Exacerbates Inflammation and Neuronal Damage in Vivo

W. Zou, Y. Wang, Y. Xia, L. Kou, T. Wang (wuhan, China)
Compound Heterozygous SCA17 in a Vietnamese Patient

C. Knight, L. Hunt, L. Fierro-Cortes, J. Pleen (Kansas City, USA)
Compound Heterozygous VPS13A Variants in a Chilean Chorea-Acanthocytosis Patient

P. Meza Castro, P. Saffie Awad, E. Fernández Toledo (Concepción, Chile)
Comprehensive Multi-Platform Proteomic Analysis Identifies Novel Biomarkers for Parkinson’s Disease Diagnosis and Progression Monitoring

D. Brazel, E. Boyle, L. Gattermeyer-Kell, M. Martinez-Serrat, C. Tafrali, W. Hu, L. Voloboueva, S. Tiwari, A. Hari, F. Qureshi, M. Khalil, P. Schwingenschuh (Menlo Park, USA)
Computer Vision Quantification of Repeated Finger Tapping Demonstrates Aberrant Plasticity in Parkinson’s Disease

D. Newbold, U. Kang (New York, USA)
COMT-Inhibitors Clinical Experience In Early Motor Fluctuations. Six Months Analysis Of REONPARK Study

L. López-Manzanares, M. Cerdán Sánchez, B. Solano Vila, J. García-Caldentey, A. Rodríguez-Sanz, J. Olivares Romero, H. Brigas, D. Martins, J. Blanco Ameijeiras, M. Rodríguez-de Miguel (Madrid, Spain)
COMT-Inhibitors Clinical Experience In Early Motor Fluctuations. Three Months Analysis Of REONPARK Study

L. López-Manzanares, M. Cerdán Sánchez, T. Delgado Ballestero, B. Solano Vila, J. García-Caldentey, A. Rodríguez-Sanz, H. Brigas, D. Martins, J. Blanco Ameijeiras, M. Rodríguez-de Miguel (Madrid, Spain)
Concomitant Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis Versus Motoneuron Phenotype of PSP in Ukrainian Patient

Y. Trufanov, Y. Compta, M. Trishchynska, N. Khanenko, G. Chupryna, V. Sereda, A. Ovchynnykova (Kyiv, Ukraine)
Conjugal Parkinsonism

CK. Tan (Singapore, Singapore)
Connectome of Pathology Stages of Progressive Supranuclear Palsy

N. Vallenas, H. Tanaka, S. Lee, G. Kovacs, B. Couto (New York, USA)
Constructing a multicenter neuroimaging dataset to unveil structural brain alterations in GNAO1-related disorders

JD. Ortigoza-Escobar, J. Dominguez-Carral, J. Romagosa Pérez, A. Schteinschnaider, L. Soliani, D. Muñoz, M. Troncoso, MC. Miranda, JJ. Nieto, A. Camacho Salas, WG. Ludlam, K. Martemyanov, J. Muchart, CS. Stephan-Otto (Barcelona, Spain)
Continued Evaluation of Bemdaneprocel Following a Phase 1 Study for Parkinson’s Disease: Outcomes Through 3 Years

H. Sarva, C. Henchcliffe, A. Lozano, A. Fasano, S. Kalia, K. Yu, C. Brennan, W. Stemple, N. Floro, N. Abid, V. Tabar (New York, USA)
Continuous Subcutaneous Apomorphine Infusion (CSAI) Reduces OFF Periods and Extends Periods of GOOD ON Time: Heatmap Analysis of the TOLEDO Study

P. Lewitt, R. Hauser, D. Kremens, A. Formella, M. Grall, M. Joshi, P. Qin (Detroit, USA)
Continuous Subcutaneous Dopaminergic Stimulation: Exploring the impact of Foslevodopa/Foscarbidopa on Gait in Parkinson’s disease.

C. O'Keeffe, J. Inocentes, M. Bradley, A. Gallagher, F. Ruggieri, R. Walsh, T. Lynch, R. Reilly, C. Fearon (Dublin, Ireland)
Continuous subcutaneous foslevodopa/foscarbidopa infusion therapy leads to a sustained reduction in dyskinesias in Parkinson’s disease

M. Georgiades, D. Tsui, X. Chen, S. Bray, J. Qiu, S. Waller, L. Williams, S. Dal, T. Ong, A. Martin, H. Morales-Briceno, V. Fung (Sydney, Australia)
Continuous, Subcutaneous Apomorphine Infusion (CSAI) for PD: Development of a Phase IV routine practice study to capture the patient, care partner, and healthcare professional experience in the United States

M. Grall, A. Christiansen, N. Maskeri, S. Reyes, P. Qin, S. Isaacson (Rockville, USA)
Contribution of Dopamine Depletion, Cerebral Perfusion, and Cognition to Gait Dysfunction in Parkinson’s Disease

HK. Na, CW. Park, Y. Sun, JH. Lee, YY. Choi, SJ. Chung, YH. Sohn, CH. Lyoo, PH. Lee (Seodaemun-gu, Republic of Korea)
Contribution of β-band functional connectivity to the α-synuclein propagation in early-stage Parkinson’s Disease: insights from the analysis of brain network properties

M. Conti, A. Guerra, V. Ferrari, V. D'Onofrio, G. Sancesario, M. Pierantozzi, NB. Mercuri, A. Antonini, T. Schirinzi, A. Stefani (Rome, Italy)
Coping with Parkinson’s Disease through the Lens of Personality Systems Interactions (PSI) Theory: Two Case Studies

E. Wünnenberg, N. Baumann (Trier, Germany)
Correlation between Orthostatic Hypotension and Cognitive Impairment in Parkinson’s Disease

M. Zhong, Y. Li, J. Liu (shanghai, China)
Correlation between the microlesional effect of subthalamic deep brain stimulation and postoperative imaging in Parkinson’s disease

J. Bejarano Hernandez, A. Ferreiros Celin, J. Rumià Arboix, P. Roldán Ramos, F. Valldeoriola Serra, A. Sánchez Gómez (Barcelona, Spain)
Correlation of 7T MRI Susceptibility and Retinal Nerve Fiber Thickness with Neurological Severity in Wilson’s Disease

I. Brum, I. Prates, J. Cordeiro, F. Otsuka, R. Guidi, P. Barbosa, R. Cury, M. Otaduy, L. Lucato, E. Barbosa, J. Parmera (Sao Paulo, Brazil)
Correlation of the FXTAS Staging System and the FXTAS Rating Scale

D. Hall, B. Ouyang, M. Tosin (Chicago, USA)
Correlational Analysis between Anxiety and Self-perception of Health in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, E. Muñoz-Alvarez (Cali, Colombia)
Correlations of catecholamine metabolites and alpha-synuclein by nigral stimulation in Parkinson’s disease model rat

T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kuwabara (Chiba, Japan)
Correlations of plasma glial fibrillary acidic protein levels with glymphatic system impairment in Huntington’s disease

JH. Yin, LY. Lu, Q. Yang, Y. Huang (Beijing, China)
Course of Impulse Control Disorder in People Living with Parkinson’s Disease: A Longitudinal Study on Dopamine Agonist Treatment

D. Náfate Wences, AE. Lopez Lobato, AJ. Hernández Medrano, AG. Cervantes Arriaga, M. Rodríguez Violante (Mexico City, Mexico)
Critical appraisal of MDS Criteria for diagnosing PD

S. Fox, . , . (Toronto, Canada)
CSF Biomarker-based Cognitive Trajectories in Parkinson’s Disease-Subjective Cognitive Decline

J. Rodriguez-Antiguedad, A. Puig-Davi, I. Ruiz-Barrio, J. Pagonabarraga, A. Vazquez-Oliver, A. Horta-Barba, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)
CSF Cadaverine and Other Polyamines as Biomarkers of Parkinson’s Disease: A PPMI Metabolomics Analysis

N. Xia, R. Maciuca, J. Suh, J. Kluss, S. Davis, R. Bakshi, G. Crotty, A. Ascherio, E. Macklin, S. Huntwork-Rodriguez, M. Schwarzschild (Charlestown, USA)
CSF Mitochondrial DNA Indicates Body Composition and Energy Metabolism in Parkinson’s Disease.

Y. Mizutani, T. Nakai, Y. Maeda, R. Ohdake, R. Nagao, S. Shima, K. Kawabata, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)
CSM-101 is a Small Molecule Agonist of TRPML1 for Parkinson’s-Related Disorders

L. Murphy, J. Fortanet, D. Baird, T. Lehmberg, K. Skerry, M. Broadus (Boston, USA)
Cutaneous Phosphorylated Alpha-Synuclein Deposition in Multiple System Atrophy

R. Freeman, T. Levine, B. Bellaire, C. Gibbons (boston, USA)